Regulation of signal transduction by endocytosis

Current Opinion in Cell Biology

Volumn 12, Issue 2, 2000, Pages 204-210

  Ceresa, Brian P ^a   Schmid, Sandra L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CELL SURFACE RECEPTOR; PROTEIN TYROSINE KINASE;

ENDOCYTOSIS; ENDOSOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034011765     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)00077-0     Document Type: Review

References (48)

1. Anderson R.G.W. The caveolae membrane system. Annu Rev Biochem. 67:1998;199-225.
2. Galbiati F., Volonte D., Engelman J.A., Watanabe G., Burk R., Pestell R.G., Lisanti M.P. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17:1998;6633-6648.
3. Engelman J.A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T., Kohtz D.S., Lisanti M.P. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. FEBS Lett. 428:1998;205-211.
4. Czarny M., Lavie Y., Fiucci G., Liscovitch M. Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. J Biol Chem. 274:1999;2717-2724.
5. Roy S., Luetterforst R., Harding A., Apolloni A., Etheridge M., Stang E., Rolls B., Hancock J.F., Parton R.G. Dominant-negative caveolin inhibits H-ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol. 1:1999;98-105. The authors demonstrate that either dominant-negative caveolin or cholesterol depletion can specifically perturb one signaling pathway, but not another.
6. Scheel J., Srinivasan J., Honnert U., Henske A., Kurzchalia T.V. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat Cell Biol. 1:1999;127-129. Using C. elegans as a model, this report shows the in vivo consequences of reduced caveolin expression or cholesterol depletion on MAP kinase signaling.
7. Engelman J.A., Lee R.J., Karnezi A., Bearss D.J., Webster M., Siegel P., Muller W.J., Windle J.J., Pestell R.G., Lisanti M.P. Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. J Biol Chem. 273:1998;20448-20455.
8. Ikonen E., Parton R.G. Caveolins and cellular cholesterol balance. Traffic. 1:2000;212-217.
9. DiGuglielmo G.M., Drake P.G., Baass P.C., Authier F., Posner B.I., Bergeron J.J. Insulin receptor internalization and signalling. Mol Cell Biochem. 182:1998;59-63.
10. Ferguson S.S., Dewney W.E. III, Colapietro A., Barak L.S., Menard L., Caron M.G. Role of β-arrestin in mediating agonist-promoted G-protein-coupled receptor internalization. Science. 271:1996;363-366.
11. Reddy C.C., Wells A., Lauffenburger D.A. Comparative mitogenic potencies of EGF and TGF alpha and their dependence on receptor-limitation versus ligand-limitation. Med Biol Eng Comput. 36:1998;499-507.
12. •].
13. •], provides a model that links differential endocytic trafficking of activated receptor tyrosine kinases with their mitogenic potential.
14. Sorkin A., DiFiore P.P., Carpenter G. The carboxyl terminus of epidermal growth factor/erbB2 chimerae is internalization impaired. Oncogene. 8:1993;3021-3028.
15. Baulinda J., Kraus M.H., Alimandi M., DiFiore P.P., Carpenter G. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem. 271:1996;5251-5257.
16. Levkowitz G., Klapper L.N., Tzahar E., Freywald A., Sela M., Yarden Y. Coupling of the c-Cbl protooncogene product to Erb-1/EGF-receptor but not to other ErbB proteins. Oncogene. 12:1996;1117-1125.
17. Yoon C.H., Lee J., Jongeward G.D., Sternberg P.W. Vulval induction during Caenorhabditis elegans development is mediated by LET-23, a homolog of the mammalian protooncogene c-cbl. Science. 269:1995;1102-1105.
18. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., Beguinot L., Geiger B., Yarden Y. c-Cbl/Sli-1 regulates ednocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:1998;3663-3674.
19. Waterman H., Lefkowitz G., Alory I., Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J Biol Chem. 274:1999;22151-22154.
20. Joazeiro C.A.P., Wing S.S., Huang H-K., Leverson J.D., Hunter T., Liu Y-C. The tyrosine kinase negative regulator c-Cbl is a RING-type, E2-dependent ubiquitin-protein ligase. Science. 286:1999;309-312. This paper presents a novel mechanism of targeting cell surface receptors for ubiquitination.
21. Strous G.J., Govers R. The ubiquitin-proteasome system and endocytosis. J Cell Sci. 112:1999;1417-1423.
22. Wang Z., Zhang L., Yeung T.K., Chen X. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol Biol Cell. 10:1999;1621-1636. The authors provide evidence that sorting signals in the ErbB1 cytoplasmic domain direct its interactions with c-Cbl and its trafficking along the lysosomal degradation pathway.
23. Waterman H., Alroy I., Strano S., Seger R., Yarden Y. The C-terminus of the kinase defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing. EMBO J. 18:1999;3348-3358.
24. Huang S.H-J., Nagane M., Klingbeil C.K., Line H., Nishikawa R., Ji X-D., Huang C-H., Gill G.N., Wiley H.S., Cavenee W.K. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem. 272:1997;2927-2935.
25. Liu E., Thor A., He M., Barcos B.M., Ljung B.M., Benz C. The Her2(c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene. 7:1992;1027-1032.
26. Khan M.N., Baquiran G., Brule C., Burgess J., Foster B., Bergeron J.J.M., Posner B.I. Internalization and activation of the rat liver insulin receptor kinase in vivo. J Biol Chem. 264:1989;12931-12940.
27. Burgess J.W., Wada I., Ling N., Khan M.N., Bergeron J.J.M., Posner B.I. Decrease in β-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin recpetor kinase. J Biol Chem. 267:1992;10077-10086.
28. Damke H., Baba T., Warnock D.E., Schmid S.L. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol. 127:1994;915-934.
29. 2-adrenergic receptor internalization by distinct mechanisms. J Biol Chem. 273:1998;34616-34622. This paper characterizes arrestins and their specificity in blocking G-protein-coupled receptor endocytosis.
30. Goodman O.B. Jr., Krupnick J.G., Santini F., Gurevish V.V., Penn R.B., Gagnon A.W., Keen J.H., Benovic J.L. Beta-arresting acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature. 383:1996;447-450.
31. Ceresa B.P., Kao A.W., Santeler S.R., Pessin J.E. Regulation of insulin receptor signaling pathways by clathrin mediated endocytosis. Mol Cell Biol. 18:1998;3862-3870.
32. Daaka Y., Luttrell L.M., Ahn S., Rocca G.J.D., Ferguson S.S.G., Caron M.G., Lefkowitz R.J. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem. 273:1998;685-688.
33. 2-adrenergic receptor subtypes. J Biol Chem 1999. 274:0052;11253-11259.
34. 1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem. 274:1999;4749-4753.
35. Vieira A.V., Lamaze C., Schmid S.L. Control of EGF receptor signaling by clatharin-mediated endocytosis. Science. 274:1996;2086-2089.
36. Vogler O., Nolte B., Voss M., Schmidt M., Jacobs K.H., van Koppen C.J. Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin. J Biol Chem. 274:1999;12333-12338.
37. Whistler J.L., von Zastrow M. Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. J Biol Chem. 274:1999;24575-24578.
38. 2-adrenergic receptors does not require agonist-elicited endocytosis. J Biol Chem. 274:1999;24935-24940.
39. Carpenter G., Soler C., Baulida J., Beguinot L., Sorkin A. Interaction of signaling and trafficking proteins with the carboxyterminus of the epidermal growth factor receptor. Ann NY Acad Sci. 7:1995;44-51.
40. 2 adrenergic receptor endocytosis.
41. 2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem. 274:1999;1185-1188.
42. i-mediated tyrosine phosphorylation of Grb2 (growth-factor-receptor-bound protein 2) - bound dynamin-II by lysophosphatidic acid. Biochem J. 339:1999;11-14.
43. Wilde A., Beattie E.C., Lem L., Tiefthof D.A., Liu S-H., Mobley W.C., Soriana P., Brodsky F.M. EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell. 96:1999;677-687.
44. 2AR signaling.
45. Lin F-T., Miller W.E., Luttrell L.M., Lefkowitz R.J. Feedback regulation of β-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem. 274:1999;15971-15974.
46. Ignatova E.G., Belcheva M.M., Bohn L.M., Neuman M.C., Coscia C.J. Requirement of receptor internalization for opiod stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J Neurosci. 19:1999;56-63.
47. Li J.G., Luo L.Y., Krupnick J.G., Benovic J.L., Liu-Chen L.Y. U50,488H-induced internalization of the human κ-opiod receptor involves a β-arrestin- and dynamin-dependent mechanism. J Biol Chem. 274:1999;12087-12094.
48. Yang W., Wang D., Richmond A. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. J Biol Chem. 274:1999;11328-11333.